Cell Works Inc.
Latest From Cell Works Inc.
Cell Works Inc.'s Circulating Cancer Cell Test can detect and characterize tumor cells in blood by separating cancer cells from the rest of the sample and scanning them in its automated microscope system. Cell Works hopes that its non-invasive tests will enable earlier disease intervention, and that its forthcoming informatics program will serve as a springboard into the prognostics and therapeutics arenas.
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, Cancer Diagnostics, features profiles of Amepersand Medical Corp., Amplistar Inc., Cell Works Inc and Cogs LLC. Plus these selected Start-ups across Health Care: Metris Therapeutics Ltd., Cardeon Corp., LabDat Inc. and Sutura Inc.
New hunters of diagnostic biomarkers hope to improve cancer diagnosis. They envision biomarkers that will allow more accurate disease-stage monitoring, more effective choice of therapy and, ultimately, the development of therapies themselves. Despite the plethora of new technologies, tools, and genomic data, however, cancer-specific markers have provent obe difficult beasts to catch.